State Street’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-215,507
| Closed | -$28.4M | – | 4012 |
|
|
2020
Q4 | $28.4M | Buy |
215,507
+2,438
| +1% | +$321K | ﹤0.01% | 2015 |
|
|
2020
Q3 | $10.8M | Sell |
213,069
-9,867
| -4% | -$499K | ﹤0.01% | 2404 |
|
|
2020
Q2 | $10.6M | Buy |
222,936
+5,491
| +3% | +$262K | ﹤0.01% | 2386 |
|
|
2020
Q1 | $10.7M | Buy |
217,445
+667
| +0.3% | +$32.7K | ﹤0.01% | 2243 |
|
|
2019
Q4 | $12.4M | Sell |
216,778
-1,542
| -0.7% | -$88.5K | ﹤0.01% | 2420 |
|
|
2019
Q3 | $7.85M | Buy |
218,320
+1,523
| +0.7% | +$54.8K | ﹤0.01% | 2585 |
|
|
2019
Q2 | $6.74M | Buy |
216,797
+11,434
| +6% | +$355K | ﹤0.01% | 2674 |
|
|
2019
Q1 | $4.82M | Buy |
205,363
+132,216
| +181% | +$3.1M | ﹤0.01% | 2763 |
|
|
2018
Q4 | $1.01M | Buy |
73,147
+46,547
| +175% | +$641K | ﹤0.01% | 3327 |
|
|
2018
Q3 | $266K | Buy |
+26,600
| New | +$266K | ﹤0.01% | 3557 |
|